KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 65 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $18,273,000 | +10.3% | 1,239,731 | -1.0% | 0.01% | +16.7% |
| Q4 2021 | $16,565,000 | -32.2% | 1,252,142 | -10.6% | 0.01% | -33.3% |
| Q3 2021 | $24,438,000 | -29.9% | 1,400,459 | -3.8% | 0.01% | -30.8% |
| Q2 2021 | $34,880,000 | +5.4% | 1,455,793 | +13.1% | 0.01% | 0.0% |
| Q1 2021 | $33,080,000 | +335.8% | 1,287,661 | +222.1% | 0.01% | +333.3% |
| Q4 2020 | $7,590,000 | +157.7% | 399,710 | +70.9% | 0.00% | +200.0% |
| Q3 2020 | $2,945,000 | -0.5% | 233,900 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $2,961,000 | +65.5% | 233,900 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $1,789,000 | -64.6% | 233,900 | -17.5% | 0.00% | -66.7% |
| Q4 2019 | $5,049,000 | – | 283,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |